| Literature DB >> 6738936 |
B S Bhagavan, T H Parmley, N B Rosenshein, J L Jefferys, J A Grisso, P D Stolley.
Abstract
Use of exogenous estrogens has been associated with endometrial cancer in a number of case-control studies. This observed association could be biased as a result of frequent misclassification of estrogen-induced hyperplasia as endometrial cancer. To evaluate this possibility, pathology slides from 233 patients with a hospital diagnosis of endometrial cancer were reviewed independently by two pathologists. The hospital diagnosis was confirmed by both pathologists in 86% of the cases, indicating that the misclassification of hyperplasia as carcinoma is uncommon.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6738936
Source DB: PubMed Journal: Obstet Gynecol ISSN： 0029-7844 Impact factor: 7.661